Skip to Main Content

Paper Details

Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial.
Nat Med
13
2022
Dapagliflozin, HFimpEF, Participants, cardiovascular, cardiovascular death, dapagliflozin, glucose, heart failure, participants, patients, sodium, sodium/glucose cotransporter 2
Author NameAffiliation
Akshay S DesaiBrigham and Women's Hospital, Harvard Medical School
Rudolf A de BoerErasmus Medical Center
Adrian F HernandezDuke University Medical Center
Carolyn S P LamNational Heart Centre Singapore and Duke-National University of Singapore
Mikhail KosiborodSaint Luke's Mid America Heart Institute and University of Missouri-Kansas City
David L DeMetsUniversity of Wisconsin
David L DeMetsUniversity of Wisconsin
  • 1 - 7

Datasets

Release 1.2